𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of interleukin-2 and interferon-γ in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432

✍ Scribed by Hiroki Yamaue; Hiroshi Tanimura; Makoto Iwahashi; Masaji Tani; Takuya Tsunoda; Katsuyoshi Tabuse; Koichi Kuribayashi; Koji Saito


Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
949 KB
Volume
29
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

✦ Synopsis


The natural-killer(NK)-cell-mediated cytotoxicity to syngeneic tumor cells can be augmented by in vivo priming and subsequent in vitro challenge with the streptococcal preparation OK432. Supernatants of cocultures of spleen cells with OK432 contained interleukin-2 (IL-2) and interferon (IFN), mainly IFN-7. As th.e anti-(mouse IFN-y) monoclonal antibody but not anti-(mouse IFN-~) antibody inhibited the induction of activated N K cells with OK432, the IFN-y participated in this response. The enhancement of N K cell activity and production of IL-2 were partially inhibited by the pretreatment of spleen cells with mitomycin C or irradiation, and were completely abolished by pretreatment with actinomycin D. The IL-2 activity after treatment with various metabolic inhibitors ran parallel to the NK activity in a system augmented with OK432. The activity of incubated spleen cells with IL-2 receptors was increased by OK432 treatment, and the N K cell and IFN activities of supernatants were also abrogated by the treatment with anti-(mouse IL-2 receptor) monoclonal antibody, to block the interaction between IL-2 and these receptors of effector cells. The panning method clarified that the incubated spleen cells with IL-2 receptors are responsible for the production of IFN-7. These results suggest that IL-2 plays a major role in inducing the activated NK cells from murine spleen cells primed in vivo and subsequently challenged in vitro with OK432, by the production of IFN-7.


📜 SIMILAR VOLUMES


In vivo anti-tumor activity of combinati
✍ Michael J. Brunda; Donna Bellantoni; Viveca Sulich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 684 KB

The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met